Beranda › Fibrilasi Atrium › Alabama
Uji klinis Fibrilasi Atrium di Alabama
11 studi untuk Fibrilasi Atrium mencari peserta di lokasi di Alabama.
Kota di Alabama
Teks studi resmi (Bahasa Inggris)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Advanced Cardiovascular, Alexander City
- SEC Clinical Research, Dothan
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- SEC Clinical Research, Dothan
- Eastern Shore Research Institute, Fairhope
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07175428A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Grandview Medical Center, Birmingham
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07527299Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- University of Alabama at Birmingham, Birmingham
- Grandview Medical Center, Birmingham
- Cardiology Associates of Mobile, Mobile
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04088071Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- SEC Clinical Research, Dothan
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07430956Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- University of Alabama at Birmingham (UAB) Hospital, Birmingham
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07298473Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Grandview, Birmingham
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06784466Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1040, Birmingham
- Anthos Investigational site 9939, Birmingham
- Anthos Investigative Site 9947, Birmingham
- dan 1 lainnya
Menerima pesertaFase 3
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05712200Tracking Results of Ablations to Combat AF Registry Generation 2
- Huntsville Hospital, Huntsville
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05111015Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- University of Alabama Hospital, Birmingham
- University of South Alabama University Hospital, Mobile
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT03907046The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
- Arrhythmia Institute at Grandview, Birmingham
- Mobile Cardiology Associates, Mobile
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Okt 2025 · NCT06324201Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.